These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 21152296

  • 1. Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.
    Ai Y, Wang ST, Sun PH, Song FJ.
    Int J Mol Sci; 2010 Sep 28; 11(10):3705-24. PubMed ID: 21152296
    [Abstract] [Full Text] [Related]

  • 2. 3D-QSAR and docking studies on pyrazolo[4,3-h]qinazoline-3-carboxamides as cyclin-dependent kinase 2 (CDK2) inhibitors.
    Lan P, Chen WN, Xiao GK, Sun PH, Chen WM.
    Bioorg Med Chem Lett; 2010 Nov 15; 20(22):6764-72. PubMed ID: 20869873
    [Abstract] [Full Text] [Related]

  • 3. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.
    Zhang G, Ren Y.
    Molecules; 2018 Nov 09; 23(11):. PubMed ID: 30423939
    [Abstract] [Full Text] [Related]

  • 4. 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
    Dessalew N, Singh SK.
    Med Chem; 2008 Jul 09; 4(4):313-21. PubMed ID: 18673142
    [Abstract] [Full Text] [Related]

  • 5. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
    Chohan TA, Chen JJ, Qian HY, Pan YL, Chen JZ.
    Mol Biosyst; 2016 Apr 09; 12(4):1250-68. PubMed ID: 26883408
    [Abstract] [Full Text] [Related]

  • 6. Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.
    Liang JD, Zhang YE, Qin F, Chen WN, Jiang WM, Fang Z, Liang XL, Zhang Q, Li J.
    J Cancer Res Clin Oncol; 2024 Jun 10; 150(6):302. PubMed ID: 38856753
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T, Zhu L, Chen L, Xu X.
    J Chem Inf Comput Sci; 2003 Jun 10; 43(1):273-87. PubMed ID: 12546563
    [Abstract] [Full Text] [Related]

  • 13. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
    Chaube U, Bhatt H.
    Mol Divers; 2017 Aug 10; 21(3):741-759. PubMed ID: 28577112
    [Abstract] [Full Text] [Related]

  • 14. Insight into the interactions between novel isoquinolin-1,3-dione derivatives and cyclin-dependent kinase 4 combining QSAR and molecular docking.
    Zheng J, Kong H, Wilson JM, Guo J, Chang Y, Yang M, Xiao G, Sun P.
    PLoS One; 2014 Aug 10; 9(4):e93704. PubMed ID: 24722522
    [Abstract] [Full Text] [Related]

  • 15. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
    Zhang B, Li Y, Zhang H, Ai C.
    Int J Mol Sci; 2010 Nov 02; 11(11):4326-47. PubMed ID: 21151441
    [Abstract] [Full Text] [Related]

  • 16. 3D-QSAR and molecular docking studies on fused pyrazoles as p38α mitogen-activated protein kinase inhibitors.
    Lan P, Huang ZJ, Sun JR, Chen WM.
    Int J Mol Sci; 2010 Sep 17; 11(9):3357-74. PubMed ID: 20957100
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
    Pourbasheer E, Aalizadeh R.
    SAR QSAR Environ Res; 2016 May 17; 27(5):385-407. PubMed ID: 27228480
    [Abstract] [Full Text] [Related]

  • 19. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G, Fan T, Zhang N, Ren T, Zhao L, Zhong R.
    Molecules; 2016 Jun 23; 21(7):. PubMed ID: 27347909
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.